Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
Join
FREE
Edition
European
US
Rheumatology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
The first and only approved dual inhibitor of IL-17A and IL-17F1-6
February 2026
BIMZELX® Demonstrated Deep and Sustained Efficacy to 3 Years Across Multiple Disease Domains of PsA and the Full axSpA Spectrum…
Read more
11 Jan 2022
Knowledge and understanding of psoriatic arthritis as a multi-domain disease, with a particular focus of skin outcomes
A discussion on the complex multi-domain disease, the diagnosis and treatment options available, and the role of the dermatologist in recognising psoriatic arthritis.
6 Jan 2022
EULAR 2021 Janssen-Sponsored symposium: “To see is to believe? Guidance on using imaging to optimize patient care in psoriatic arthritis”.
This podcast reviews presentations at EULAR focusing on the emerging role of X-ray, ultrasound, and MRI in the management of PsA in the clinical setting.
6 Jan 2022
EULAR 2021 Janssen-Sponsored symposium: “The launching pad: exploring the potential of the IL-23 pathway in psoriatic arthritis.”
This episode highlights both the role of the IL-23 pathway in the pathogenesis of PsA and the potential IL-23 inhibitors hold for improving PsA outcomes.
10
Mins
15 Nov 2021
The Safety of Medications During Pregnancy and Lactation in Patients with Inflammatory Rheumatic Diseases
The majority of inflammatory rheumatic diseases (IRDs) affect females more frequently and many have peaks in their childbearing age…
4
Mins
8 Nov 2021
The Association Between Hypermobility Ehlers–Danlos Syndrome and Other Rheumatologic Diseases
In this feature paper, the authors discuss the prevalence and pathophysiology of rheumatologic conditions, specifically ankylosing spondylitis and rheumatoid arthritis, in patients with hEDS.
29 Oct 2021
Treatment Tapering and Withdrawal in People with Rheumatoid Arthritis in Stable Remission
The Rheumatoid Arthritis in Ongoing Remission (RETRO) study aimed to determine outcomes following tapering and withdrawal…
29 Oct 2021
COVID-19 Vaccination in People with Multiple Sclerosis
Consequently, for interferon-β, teriflunomide, and dimethyl fumarate, COVID-19 vaccination is “likely to be effective…”
11
Mins
22 Oct 2021
Latest News and Advancements Within the Areas of Axial Spondyloarthritis and Psoriatic Arthritis Featured at EULAR 2021
The chronic inflammatory diseases axial spondyloarthritis (AxS) and psoriatic arthritis (PsA) involve symptoms such as axial skeleton pain…
Loading posts...
« Previous
1
…
45
46
47
48
49
…
83
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View